5 Pharmaceutical preparations for the treatment of diseases of the central nervous system (CNS), Alzeimer's, Parkinson's, stroke, schizophrenia, depression, cancer; biopharmaceutical preparations for the treatment of diseases of the central nervous system, Alzeimer's, Parkinson's, stroke, schizophrenia, depression, cancer; pharmaceutical preparations in the nature of small molecules for diseases of the central nervous system, Alzeimer's, Parkinson's, stroke, schizophrenia, depression, cancer; and biological preparations for medical purposes